← Leaderboards
Xiaowei Xu
University Of Pennsylvania
$9,845,570
Attributed
$11,195,789
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,195,789 · 8
By mechanism
R01$5,862,669 · 3
P50$3,161,530 · 3
P01$1,782,181 · 1
R21$389,409 · 1
Top collaborators
- Meenhard Herlyn5 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Robert H Vonderheide$28,425,019
- Meenhard Herlyn$50,214,821
- Michael S Marks$18,307,737
- Rahim R Rizi$49,177,138
- David A Mankoff$17,196,499
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaClinical TrialsTissuesCellsMolecularMelanoma CellTumorProceduresResearch PersonnelSkin CancerProteinsSamplingCell LineProgramsHumanized MouseLaboratoriesCollaborationsMouse ModelImmunotherapyParaffin EmbeddingPathologicPatient Derived Xenograft ModelGuidelinesInstitution
Grant awards (30)
Designer extracellular vesicles for cancer therapy$645,726
R01 · FY2025 · CA · contact PI
Gamma delta T cell based melanoma therapies$634,246
R01 · FY2025 · CA · contact PI
Biospecimen and Pathology Core$308,750
P50 · FY2025 · CA · contact PI
Designer extracellular vesicles for cancer therapy$662,946
R01 · FY2024 · CA · contact PI
Gamma delta T cell based melanoma therapies$608,024
R01 · FY2024 · CA · contact PI
Biospecimen and Pathology Core$296,400
P50 · FY2024 · CA · contact PI
Gamma delta T cell based melanoma therapies$632,718
R01 · FY2023 · CA · contact PI
Pathology Core$353,882
P01 · FY2023 · CA · contact PI
Biospecimen and Pathology Core$287,140
P50 · FY2023 · CA · contact PI
Explore Gamma delta T cell-based glioblastoma therapies$158,750
R01 · FY2023 · CA · contact PI
Gamma delta T cell based melanoma therapies$666,701
R01 · FY2022 · CA · contact PI
Pathology Core$416,024
P01 · FY2022 · CA · contact PI
Biospecimen and Pathology Core$286,862
P50 · FY2022 · CA · contact PI
Pathology Core$426,198
P01 · FY2021 · CA · contact PI
Biospecimen and Pathology Core$307,897
P50 · FY2021 · CA · contact PI
Pathology Core$150,946
P01 · FY2020 · CA · contact PI
Pathology Core$435,131
P01 · FY2019 · CA · contact PI
Biospecimen and Pathology Core$347,155
P50 · FY2018 · CA · contact PI
Biospecimen and Pathology Core$338,762
P50 · FY2017 · CA · contact PI
Biospecimen and Pathology Core$358,305
P50 · FY2016 · CA · contact PI
Biospecimen and Pathology Core$317,715
P50 · FY2015 · CA · contact PI
Biospecimen and Pathology Core$312,544
P50 · FY2014 · CA · contact PI
Characterization of neural crest stem cells in human hair follicles.$319,958
R01 · FY2013 · AR · contact PI
Characterization of neural crest stem cells in human hair follicles.$336,798
R01 · FY2012 · AR · contact PI
Characterization of neural crest stem cells in human hair follicles.$336,798
R01 · FY2011 · AR · contact PI
Characterization of neural crest stem cells in human hair follicles.$350,831
R01 · FY2010 · AR · contact PI
Characterization of neural crest stem cells in human hair follicles$162,560
R01 · FY2010 · AR · contact PI
Characterization of neural crest stem cells in human hair follicles.$346,613
R01 · FY2009 · AR · contact PI
Ultrasensitive FACTT assays for serum biomarkers$212,482
R21 · FY2008 · CA · contact PI
Ultrasensitive FACTT assays for serum biomarkers$176,927
R21 · FY2007 · CA · contact PI